1. Reports of misoprostol misuse in Brazil cause concern

   Newsletter Article 31 January 2013 Pages: 1 - 1

2. Prostaglandin inhibitors should be used with care during pregnancy

   Newsletter Article 31 January 2013 Pages: 1 - 1

3. Patients with HIV infection are at increased risk of severe cutaneous reactions …

   Newsletter Article 31 January 2013 Pages: 2 - 2

4. … and the extent of this risk should be assessed

   Newsletter Article 31 January 2013 Pages: 2 - 3

5. No difference in cancer risk is seen between cyclosporin and azathioprine

   Newsletter Article 31 January 2013 Pages: 3 - 3

6. Alteplase/heparin

   Newsletter Article 31 January 2013 Pages: 3 - 3

7. Amlexanox

   Newsletter Article 31 January 2013 Pages: 3 - 3

8. Amoxicillin/naproxen

   Newsletter Article 31 January 2013 Pages: 4 - 4

9. Anaesthetics

   Newsletter Article 31 January 2013 Pages: 4 - 4

10. Antacid

    Newsletter Article 31 January 2013 Pages: 4 - 4

11. Antilymphocyte immunoglobulin/muromonab CD3

    Newsletter Article 31 January 2013 Pages: 4 - 4

12. Antineoplastics

    Newsletter Article 31 January 2013 Pages: 4 - 4

13. Antipsychotics

    Newsletter Article 31 January 2013 Pages: 5 - 5

14. Antituberculars see Fluconazole interaction

    Newsletter Article 31 January 2013 Pages: 5 - 5

15. Atropine see Diphenoxylate + atropine

    Newsletter Article 31 January 2013 Pages: 5 - 5

16. Atropine + diphenoxylate overdose

    Newsletter Article 31 January 2013 Pages: 5 - 5

17. Beta blockers

    Newsletter Article 31 January 2013 Pages: 5 - 5

18. Bleomycin

    Newsletter Article 31 January 2013 Pages: 5 - 5

19. Busulfan/cyclophosphamide

    Newsletter Article 31 January 2013 Pages: 5 - 5

20. Calcium chloride

    Newsletter Article 31 January 2013 Pages: 5 - 5

21. Carbamazepine

    Newsletter Article 31 January 2013 Pages: 5 - 6

22. Carbamazepine see Cyclosporin interaction

    Newsletter Article 31 January 2013 Pages: 6 - 6

23. Ceftriaxone

    Newsletter Article 31 January 2013 Pages: 6 - 6

24. Ciprofibrate

    Newsletter Article 31 January 2013 Pages: 6 - 6

25. Cisplatin

    Newsletter Article 31 January 2013 Pages: 6 - 6

26. Cocaine abuse

    Newsletter Article 31 January 2013 Pages: 6 - 6

27. Colchicine

    Newsletter Article 31 January 2013 Pages: 6 - 7

28. Cyclophosphamide see Busulfan/cyclophosphamide

    Newsletter Article 31 January 2013 Pages: 7 - 7

29. Cyclosporin

    Newsletter Article 31 January 2013 Pages: 7 - 7

30. Cyclosporin interaction

    Newsletter Article 31 January 2013 Pages: 7 - 7

31. Diazepam see Papaverine interaction

    Newsletter Article 31 January 2013 Pages: 7 - 7

32. Diphenoxylate + atropine

    Newsletter Article 31 January 2013 Pages: 7 - 8

33. Diphenoxylate see Atropine + diphenoxylate overdose

    Newsletter Article 31 January 2013 Pages: 8 - 8

34. Etretinate see Warfarin interaction

    Newsletter Article 31 January 2013 Pages: 8 - 8

35. FK 506

    Newsletter Article 31 January 2013 Pages: 8 - 8

36. Fluconazole interaction

    Newsletter Article 31 January 2013 Pages: 8 - 8

37. Fluoxetine

    Newsletter Article 31 January 2013 Pages: 8 - 8

38. Fluoxetine interaction

    Newsletter Article 31 January 2013 Pages: 8 - 8

39. Glucocorticosteroids

    Newsletter Article 31 January 2013 Pages: 8 - 9

40. Griseofulvin see Cyclosporin interaction

    Newsletter Article 31 January 2013 Pages: 9 - 9

41. Heparin

    Newsletter Article 31 January 2013 Pages: 9 - 9

42. Heparin see Alteplase/heparin

    Newsletter Article 31 January 2013 Pages: 9 - 9

43. Ibuprofen see Lithium interaction

    Newsletter Article 31 January 2013 Pages: 9 - 9

44. Idoxuridine

    Newsletter Article 31 January 2013 Pages: 9 - 9

45. Immunosuppressants

    Newsletter Article 31 January 2013 Pages: 9 - 9

46. Isoniazid

    Newsletter Article 31 January 2013 Pages: 9 - 9

47. Ketorolac

    Newsletter Article 31 January 2013 Pages: 9 - 9

48. Lisinopril see Lithium interaction

    Newsletter Article 31 January 2013 Pages: 9 - 9

49. Lithium interaction

    Newsletter Article 31 January 2013 Pages: 9 - 10

50. Methotrexate

    Newsletter Article 31 January 2013 Pages: 10 - 10